In our study, we evaluated a large number of myeloma patients and found that patients with NDMM had higher levels of VCAM-1 and ICAM-1 compared with MGUS patients and higher VCAM-1 levels compared with SMM patients. Here, VCAM1 is linked to plasma cell myeloma.